头孢尼西钠，CAS 登记号 61270-78-8，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于无机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
无机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 头孢尼西钠 的 CAS 号：61270-78-8，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及无机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
Cefonicid sodium · CAS 61270-78-8 · C18H16N6Na2O8S3. UNII F74MFL78A1.
| CAS Registry Number | 61270-78-8 |
|---|---|
| PubChem CID | 43593 |
| Molecular formula | C18H16N6Na2O8S3 |
| IUPAC name | disodium;(6R,7R)-7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-8-oxo-3-[[1-(sulfonatomethyl)tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
| UNII (FDA) | F74MFL78A1 |
| Molecular Weight | 586.5 |
|---|---|
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 7 |
| Exact Mass | 585.99871357 |
| Monoisotopic Mass | 585.99871357 |
| Topological Polar Surface Area | 270 |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 980 |
| Reported hazard statements | H317 (100%), H334 (100%) |
|---|
H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]
H334 (100%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]
CEFONICID SODIUM; 61270-78-8; Cefonicid disodium salt; Monocid; Cefonicide sodium; DTXSID0046642; F74MFL78A1; SK&F D-75073-Z(SUB 2); SK&F-D-75073-Z(SUB 2); CHEBI:3492; DTXCID8026642; RefChem:57270; 190181-58-9; SK&F D-75073-Z2; Cefonicid (sodium); SK&F-D-75073-Z2
CAS 61270-78-8; molecular formula C18H16N6Na2O8S3; molecular weight — g/mol.
CEFONICID SODIUM, 61270-78-8, Cefonicid disodium salt, Monocid, Cefonicide sodium, DTXSID0046642.
Hazard statements reported: H317, H334.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.